Injection device with end-of-dose indicator

By introducing a hidden device into the injection device, the end-of-dosing indicator automatically moves from the hidden position to the visible position during the injection process, solving the problem of difficult to identify the injection completion moment in the prior art, and achieving low cost and easy-to-manufacturing The injection completes signal delivery.

CN114423476BActive Publication Date: 2024-11-12BECTON DICKINSON FRANCE SAS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080065615.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-10-23
Filing Date
2020-10-14
Publication Date
2024-11-12
Estimated Expiration
2040-10-14

AI Technical Summary

Technical Problem

The drug delivery end indicator of the existing injection device gradually moves during the injection process, making it difficult to clearly identify the injection completion time, and is costly or difficult to manufacture, which limits its use.

Method used

An injection device including a drug end-of-dosing indicator is designed, using a hidden device to automatically move the indicator from the hidden position to the visible position during the injection process, unlocked through the triggering part of the plunger unit, providing a clear injection completion signal, and The device is low cost and easy to manufacture.

Benefits of technology

It realizes clearly visible indications when injection is completed, reduces manufacturing and use costs, avoids unexpected triggers, and simplifies device design and operation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114423476B_ABST
    Figure CN114423476B_ABST
Patent Text Reader

Abstract

An injection device for injecting a substance, comprising: a housing (120) receiving a barrel (102) containing a substance to be injected and comprising a stopper (103) movable within the barrel, a plunger unit (110) comprising a trigger portion, the plunger unit (110) being connected to the stopper (103) and being movable relative to the housing (120) from an initial proximal position to a final distal position to inject the substance when the barrel (102) enters the housing (120), an end-of-dose indicator (160) movable from a concealed position to a visible position in which at least a portion of the end-of-dose indicator (160) is visible to a user, and a hiding device for locking the end-of-dose indicator (160) in the concealed position and configured to be unlocked by the trigger portion of the plunger unit when the plunger unit (110) reaches the indicator position.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to an injection device, in particular, the present invention relates to a medical injection device comprising an end-of-dose indicator, wherein the end-of-dose indicator is arranged to notify a user of the end of injection. Background Art

[0002] Injection devices including end-of-dose indicators are known. Such end-of-dose indicators typically adopt a first position before and during injection of the substance and a second position at the end of the injection to inform the user that the injection is complete and the injection device can be removed from the body.

[0003] However, the end-of-dose indicator of the prior art usually moves gradually from the first position to the second position, i.e., as the injection of the substance proceeds. Therefore, it may be difficult for the user to see the exact moment when the injection is completed. In addition, the end-of-dose indicator may also be expensive or difficult to manufacture, which may limit its use in injection devices. Summary of the invention

[0004] The present invention aims to overcome the above-mentioned defects of the prior art and proposes an injection device including an end-of-dose indicator for providing a clear signal that the injection is completed. In addition, the injection device is low in cost and easy to manufacture.

[0005] To this end, a first aspect of the present invention is an injection device for injecting a substance into a body, comprising:

[0006] - a housing including elastic means and adapted to receive and retain a barrel containing a substance to be injected, said barrel including a bung movable in sliding engagement within said barrel,

[0007] a plunger unit, including a trigger portion, adapted to be coupled to the bung and movable relative to the housing from an initial proximal position to a final distal position for injecting the substance when the barrel enters the housing,

[0008] an end-of-dose indicator housed in the housing and movable under the force of the elastic means from a hidden position in which the end-of-dose indicator is hidden from a user to a visible position in which at least a portion of the end-of-dose indicator is visible to a user,

[0009] - hiding means for locking the end-of-dose indicator in the hidden position and configured to be unlocked by a trigger portion of the plunger unit when the plunger unit reaches the indicator position during its injection movement from the initial proximal position to the final distal position so as to allow the end-of-dose indicator to automatically move to the visible position.

[0010] Due to the concealing device, the end-of-dose indicator can pop up in a short single movement, thereby clearly indicating that the injection has been completed. For example, the length of the movement is 1mm to 1cm, preferably 2-8mm and more preferably 4-6mm or 5mm. In addition, the concealing device is directly unlocked by the trigger part of the plunger unit, thereby allowing reliable active triggering to be achieved in the end of the injection movement of the plunger unit. Preferably, the plunger unit is configured to move manually, that is, to move under the action of the force applied by the user. Alternatively, the plunger unit can move under the action of the force of a spring or a motor.

[0011] For example, the indicator position may be between 85% and 100% of the injection movement of the plunger unit, and preferably between 95% and 100% or 97% and 100%. In other words, the indicator position is at the last part of the injection movement of the plunger unit, just before the final distal position or at the final distal position.

[0012] Advantageously, the concealing means comprises:

[0013] - at least one indicator stop disposed on one of the housing and the end-of-dose indicator,

[0014] - at least one flexible arm provided on the other of the housing and the end-of-dose indicator and arranged to contact the indicator stop when the end-of-dose indicator is in the concealed position,

[0015] Wherein, the flexible arm is configured to deflect under the action of the trigger portion of the plunger unit to release contact with the abutment surface, thereby unlocking the hiding device.

[0016] Such an end-of-dose indicator and such a concealing device are easy to manufacture and provide reliable triggering. In addition, they can prevent accidental triggering, for example, due to impacts during manufacturing, transportation or operation. Preferably, two flexible arms are provided, preferably on the end-of-dose indicator. More preferably, two indicator stops are provided on or inside the housing.

[0017] Advantageously, the trigger portion comprises a rigid leg and the flexible arm comprises a slope forming an angle with the longitudinal axis of the rigid leg. This configuration can make the unlocking of the concealment device smoother and minimize the hard point feeling of the user performing the injection. The trigger portion can be one rigid leg, and preferably two rigid legs that can protrude from the plunger unit.

[0018] Advantageously, the end-of-dose indicator is adapted to move in the proximal direction from the concealed position to the visible position. Such movement, which is opposite to the injection movement, can be more easily perceived by the user. For example, the movement can be linear, thereby simplifying the design and manufacture of the injection device. The movement of the plunger unit is also preferably linear, so as to simplify the manufacture and operation of the injection device.

[0019] Advantageously, the housing includes a window, and at least a portion of the end-of-dose indicator includes a tab that is configured to pop out of the window when the end-of-dose indicator moves to the visible position. The window can be covered with a transparent material, or can simply include an opening in the housing. The window is valuable for inspecting the substance and the barrel before injection and protecting the movement of the end-of-dose indicator.

[0020] Advantageously, the plunger unit comprises a tubular member provided with the trigger portion, wherein the tubular member is adapted to cover at least a portion of the housing when the plunger unit is in the final distal position. Thus, the tubular member indicates that the injection device has been used when it covers the housing and may preferably obscure at least a portion or a large portion of a window of the housing.

[0021] Advantageously, the housing comprises a distal ring accommodating the end-of-dose indicator. This allows accommodating the end-of-dose indicator at a location remote from the barrel and the plunger unit, thereby simplifying the manufacture of the injection device.

[0022] Advantageously, the tubular member comprises an end face and the distal ring defines an abutment surface adapted to contact the end face when the plunger unit is in the final distal position. Thus, the injection device is in a "closed" design at the end of the injection, which prevents any reuse and facilitates safe disposal of the used injection device. Alternatively or in combination, a new cartridge may be loaded into the housing and another injection may be performed.

[0023] Advantageously, at least a portion of the window is arranged on the distal ring. When the dosing end indicator is in the visible position, the portion of the dosing end indicator can preferably be visible in this portion of the window. Therefore, the user can see the stopper in the distal portion of the barrel and the dosing end indicator in the visible position. When the housing is covered by the tubular member, this also allows the user to see the dosing end indicator.

[0024] Advantageously, the injection device comprises a barrel held in the housing, the barrel containing the substance to be injected and comprising a stopper and an injection needle that can be moved in sliding engagement. For example, the barrel comprises a proximal flange, and the barrel is held in the housing by the flange.

[0025] Advantageously, the injection device further comprises:

[0026] a needle guard arranged to be movable under the force of said elastic means from an injection position in which said needle guard is movable relative to said injection needle to a safety position in which said needle guard permanently covers said injection needle, said needle guard being provided with a flexible leg comprising a guard stop,

[0027] - the housing further comprises an operation stop configured to prevent the needle guard from moving to the safety position by abutting the guard stop,

[0028] - the trigger portion is further configured to deflect the flexible legs of the needle guard when the plunger unit has reached the trigger position during its injection movement so as to disengage the guard stop and the operating stop and allow the needle guard to reach the safety position under the force of the resilient means.

[0029] For example, the same rigid leg or another rigid leg of the trigger portion may be configured to unlock the flexible leg.The needle guard may prevent any unwanted needle sticks, thereby providing safe handling and safe disposal of the injection device.

[0030] Advantageously, the indicator position is a threshold position located after the trigger position in the injection movement of the plunger unit. For example, the trigger position may be at 85% to 95% of the injection movement, while the indicator position may be at 96% to 100% of the injection movement of the plunger unit.

[0031] Advantageously, the injection device further comprises a safety lock, the safety lock being arranged to lock the needle guard and / or the guard stop when the needle guard is in the safety position. The safety lock may prevent or limit movement of the needle guard in the safety position. For example, the safety lock may comprise a safety stop, the safety stop being arranged on the housing and abutting the guard stop when the needle guard is in the safety position.

[0032] The operating stop of the housing may act as a safety stop by limiting the retraction or proximal movement of the needle guard in the safety position. Thus, when the needle guard is in the safety position, the flexible legs of the needle guard may not be deflected, i.e. in their initial state, in order to allow such abutment. In other words, the triggering portion of the plunger unit may be configured to deflect the flexible legs only when the needle guard is in the retracted proximal position.

[0033] Alternatively or in combination, the trigger portion or another part of the plunger unit may provide a safety lock in the final distal position of the plunger unit, e.g. by direct contact with the needle guard and / or with the flexible legs, thereby simplifying the manufacture of the injection device.

[0034] Advantageously, the safety lock comprises at least one flexible tab provided on the housing, and the trigger portion is further configured to deflect the flexible tab to place it in abutment with the guard stop when the plunger unit has reached the safety lock position during its injection movement. This contributes to a reliable safety position of the thin injection device and the needle guard. Alternatively, the flexible tab may be a rotating tab. The safety lock position may be the same as the trigger position of the plunger unit, or closer to the final distal position of the plunger unit. For example, the trigger position may be at 85% to 90% of the injection movement of the plunger unit, while the safety lock position may be at 90% or 91% to 95% or 96% of the injection movement of the plunger unit.

[0035] For example, the trigger portion comprises at least one rigid leg, e.g. parallel to the longitudinal axis of the injection device, arranged to interact with the flexible leg of the needle guard. Optionally, the trigger portion comprises another rigid leg, which may also be longitudinal and arranged to interact with the flexible tab. For example, the longitudinal rigid leg may have different lengths, i.e. may protrude from the plunger unit with different lengths, so as to interact with the flexible leg of the needle guard and the flexible tab of the housing at the same threshold position of the plunger unit (i.e. the trigger position) or at two different threshold positions (i.e. the trigger position and the safety lock position).

[0036] Alternatively or in combination, the trigger portion may include an abutment surface or protrusion provided on the plunger unit. The trigger position may include two, three or four rigid legs, the needle guard may include two, three of the four flexible legs, and the housing may include two, three of the four operating stops. Each rigid leg is preferably configured to align with the operating stop and the flexible leg on the longitudinal axis or the proximal-distal axis of the injection device. In addition, two end-of-dose indicators may be provided, each having two flexible arms. In this case, the trigger portion may preferably include two or four additional legs, preferably aligned with each flexible arm of each end-of-dose indicator on the longitudinal axis or the proximal-distal axis of the injection device. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] Other features and advantages of the invention will appear more clearly from the following detailed description of certain non-limiting examples of the invention illustrated by the accompanying drawings, in which:

[0038] - Figure 1 shows a perspective view of an injection device according to the invention, as presented during storage or transport;

[0039] - Figure 2 Shown in ready-to-use state without handle Figure 1 A stereoscopic view of an injection device;

[0040] - Figure 3 Show according to Figure 2 A cross-sectional view of an injection device;

[0041] - Figure 4 Show Figure 3 A perspective view of an injection device without a plunger unit;

[0042] - Figure 5 A perspective cross-sectional view showing a plunger unit of an injection device;

[0043] - Figure 6 Show Figure 2 A side view of a distal portion of an injection device of , in a ready-to-use state with a needle guard in an extended position;

[0044] - Figure 7 The needle guard is shown in the retracted position. Figure 2 A side view of a distal portion of an injection device;

[0045] - Figure 8 The needle guard is shown in the retracted position. Figure 2 A side view of a distal portion of the injection device, wherein the plunger unit has been moved distally;

[0046] - Fig. 9 The needle guard is shown in the retracted position. Figure 2 A side view of a distal portion of an injection device, wherein the plunger unit is in a final distal position;

[0047] - Fig.10 Showing the needle guard in the safe position Figure 2 A side view of a distal portion of an injection device, wherein the plunger unit is in a final distal position;

[0048] - Fig.11 Shows safe position Figure 2 A cross-sectional side view of an injection device with the plunger unit in a final distal position;

[0049] - Fig.12 Shown in ready-to-use position Figure 2 A perspective view of a distal portion of an injection device of , wherein the needle guard is omitted;

[0050] - Fig.13 Show Fig.12 a cross-sectional view of a distal portion of an injection device of , wherein an end-of-dose indicator is shown in a concealed position;

[0051] - Fig.14 The plunger unit is shown in the final distal position and the end-of-dose indicator is triggered. Fig.12 a cross-sectional view of a distal portion of an injection device;

[0052] - Fig.15 The plunger unit is shown in the final distal position after the end-of-dose indicator has been triggered. Fig.12 a cross-sectional view of a distal portion of an injection device;

[0053] - Fig.16 The plunger unit is shown in the final distal position. Fig.12 A cross-sectional view of the distal portion of an injection device with an end-of-dose indicator in a visible position. DETAILED DESCRIPTION

[0054] The injection system of the present invention is intended for administration of substances, such as parenteral pharmaceutical compositions, by a health care provider or by a patient with simplified manipulation and a clear visual indicator showing when the substance has been completely injected.

[0055] Therefore, in the present application, the distal direction needs to be understood as the injection direction relative to the medical injection system, while the proximal direction is the opposite direction, i.e., the direction towards the hand of the medical caregiver or the patient. In addition, a substance or a pharmaceutical composition needs to be understood as various injectable pharmaceutical compositions suitable for therapeutic, aesthetic, prophylactic or diagnostic applications.

[0056] refer to Figures 1 to 5 , shows an injection device according to a preferred embodiment of the present invention, which is in a ready-to-use state, that is, it can be used by the user after being taken out from the blister package.

[0057] like Figures 2 to 4 As shown, the injection device includes a housing 120 that receives a syringe 100 having a barrel 102 (only in the Figure 3 As is known from the prior art, the barrel 102 is provided with a fixed or removable injection needle 101 suitable for piercing a patient's body and a stopper 103 slidably engaged in the barrel (102). The barrel 102 also includes a proximal flange 104, which is retained by the housing so that the housing accommodates and fixes the barrel 102. The injection needle 101 may be provided with a needle cap 140 covering the injection needle 101 during storage and transportation of the injection device.

[0058] The housing 120 includes a distal portion 120a and a proximal portion 120b, the distal portion 120a can define a distal ring 125, the distal ring 125 having a width or diameter greater than the proximal portion 120b. The distal ring 125 can include an abutment surface 125a facing in the proximal direction. The housing 120 also includes a resilient device 121, an operating stop 122, and a flexible tab 123. An optional window 124 can visualize the barrel 102 and the substance contained therein.

[0059] The housing is covered with an optional cover handle 150 (only in Figure 1 120 ), which is intended to cover the housing 120 so as to be easily grasped and held by the hand of a user making an injection. The handle 150 can be fixed or clamped on the housing 120 by its distal end, i.e. on or near the distal ring 125. The proximal portion 120b of the housing 120 includes one or two locking recesses 126.

[0060] The plunger unit 110, in Figure 2 , Figure 3 as well as Figure 5 The plunger unit 110 is more visible in the figure, adapted to slide relative to the housing 120 and coupled to the stopper 103 via the distal end 114d of the plunger shaft 114. The plunger unit 110 includes an outer tubular member 113 adapted to cover at least a portion of the housing 120 and slide between the housing 120 and the handle 150. The plunger unit 110 can be moved from an initial proximal position (e.g., a distal end) by a user applying a manual force on the push surface 110b. Figures 1 to 3 ) to the final distal position (as shown) Fig.11 ) to inject the substance into the patient.

[0061] The plunger unit 110 further comprises a trigger portion in the form of two longitudinal rigid legs 111, 112 of different lengths, wherein the longest rigid leg 112 protrudes distally from the tubular member 113 relative to the shortest rigid leg 111. For example, one or more trigger portions may be provided on the plunger unit 110. Furthermore, the plunger unit 110 further comprises one or two inclined arms 115, which protrude proximally from the tubular member 113 and are used to cooperate with the locking recess 126 when the plunger unit 110 is in the final distal position. For example, four trigger portions are provided on the plunger unit 110.

[0062] The optional needle guard 130 is partially housed within the distal ring 125 of the housing 120 and is slidable from the perspective of the housing in an injection position where an injection can be made (see FIG. Figures 1 to 5 In this injection position, the needle guard 130 can be moved from the deployed position covering the injection needle (101) (see Figures 1 to 6 ) to a retracted position in which at least a portion of the injection needle is uncovered (see Figure 7 ). Furthermore, the needle guard 130 is arranged to be movable from the injection position to a safety position, away from the deployed position, and in this position the needle guard 130 permanently covers the injection needle 101 .

[0063] The optional needle guard 130 is provided with at least one flexible leg 131 extending proximally and comprising a guard stop 132, such as a protrusion and a proximal inclined portion 132b. The elastic means 121 is provided in the housing 120, for example, in the distal ring 125, so as to apply a distal force to the needle guard 130. The elastic means may include a cylindrical steel spring abutting a surface provided inside the housing 120, such as a distal face of the abutment surface 125a.

[0064] refer to Figure 2 and Figure 4 The housing 120 further includes an operation stop 122 for preventing the needle guard 130 from moving to a safe position by contacting the guard stop 132 when the needle guard 130 is in the deployed position. Figure 2 , Figure 3 as well as Figure 6 Therefore, in the injection position of the needle guard 130, when the needle guard 130 moves from the extended position to the retracted position, the guard stopper 132 can move from the position in contact with the operation stopper 122 to the position close to the operation stopper 122 (see Figure 6 and Figure 7). In the retracted position, the needle guard may be stopped by the elastic means 121. This proximal movement of the needle guard 130 is intended to be performed when the injection device is pressed against the body with a force greater than the elastic means 121 and as many times as is necessary to complete the injection.

[0065] In the drawings, two trigger portions, two operation stops, and two flexible legs are visible, but one or three of the four may be provided in corresponding or aligned positions.

[0066] Operation of the injection device

[0067] In operation, the injection device can be taken out from the blister or package, and the needle cap 140 can be removed from the injection needle 101. At this time, the injection needle 101 is covered by the needle guard 130, thereby avoiding needle phobia.

[0068] The injection device is then pressed against the patient's body and, in the injection position, the needle guard 130 is moved proximally from the deployed position to a retracted position in which the guard stop 132 of the needle guard 130 is not in contact with the operating stop 122 and the needle guard 130 does not cover at least a portion of the injection needle 101 (see Figure 6 and Figure 7 ). The injection needle 101 thus penetrates into the patient's body and performs a puncture.

[0069] In this regard, the patient or user may prefer to change the injection site for medical and / or convenience reasons. The injection device can make such changes due to the injection position of the needle guard 130. When the injection device is removed from the patient before the injection is completed, the needle guard 130 is pushed from the retracted position to the deployed position by the elastic device 121, but is prevented from reaching the safe position by the operation stopper 122. Therefore, the injection needle is covered at all times, especially when it is not inserted into the patient's body, and the same puncture operation can be reproduced at another injection site of the body.

[0070] When the patient or user is satisfied with the injection site, the push surface 110b of the plunger unit 110 can be pressed, thereby causing the stopper 103 to move distally and inject the substance into the body. This distal movement of the plunger unit 110 causes the trigger portion (rigid legs 111 and 112) of the plunger unit 110 to move closer to the flexible legs 131 of the needle guard 130 and the flexible tabs 123 of the housing 120, such as Figure 7 shown.

[0071] When the plunger unit 110 has reached the first threshold position or the trigger position, preferably at the end of its injection movement, the shortest rigid leg 111 is in contact with the proximal end of the flexible leg 131 and the proximal inclined portion 131b, as shown in FIG. Figure 7 As shown. Figure 7 The arrows shown in Figure 8 As shown, as the plunger unit 110 moves further in the distal direction to complete the injection, the shortest rigid leg 111 contacts and deflects the flexible leg 131 due to its proximal inclined portion 131 b.

[0072] In the safety locking position of the plunger unit 110, which corresponds to the first threshold position or the second threshold position in the injection movement of the plunger unit 110, the longest rigid leg 112 is in contact with the flexible tab 123. Figure 8 The circular arrow and Fig. 9 As shown, the flexible tab 123 moves into the space away from the operating stop 122. The plunger unit 110 still moves in the distal direction under the force of the user, and the shortest rigid leg 111 moves into the space proximal to the operating stop 122 until it abuts against the operating stop 122. The flexible leg 131 remains in the deflected position, and the shortest rigid leg 111 occupies the space previously occupied by the flexible leg 131, as shown in FIG. Fig. 9 At the same time, the longest rigid leg 112 moves toward the distal ring 125 and holds the flexible tab 123 in a deflected position away from the operating stop 122 .

[0073] At the end of the injection, when the plunger unit 110 reaches its final distal position and all the substance contained in the barrel 102 has been transferred into the body through the injection needle 101, the injection device is Fig. 9 and Fig.10 1 , wherein the shortest rigid leg 111 abuts the operating stop 122. Alternatively or in combination, this final position corresponds to a position in which the bung 103 abuts the distal end of the barrel 102.

[0074] The injection device is then removed from the injection site, and the needle guard 130 is pushed distally by the elastic means 121. However, the flexible legs 131 are still deflected by the shortest rigid legs 111, and the guard stop 132 no longer contacts the operational stop 122. When the needle guard moves distally, the guard stop 132 reaches a space located away from the operational stop 122, in which space it stops at the abutment surface 125a of the distal ring 125. In addition, any proximal movement of the needle guard is prevented by the contact between the guard stop 132 and the flexible tab 123, which is held in a flexible position by the longest rigid leg 112, as shown in FIG. Fig.10 shown.

[0075] exist Fig.10In the embodiment, the needle guard is in a safe position covering the entire injection needle 101 to avoid any needle stick injury and is prevented from moving proximally by the abutment between the guard stop 132 of the flexible leg 131 and the flexible tab 123 of the housing 120. Therefore, the shortest rigid leg 111 and the longest rigid leg 112 act as a trigger portion to trigger the needle guard 130 to be in the safe position by allowing the flexible leg 131 to disengage from the operating stop 122 and the flexible tab 123 to reach its abutment position which can serve as a safety lock.

[0076] like Fig.11 As shown, when the plunger unit 110 is in the final distal position, the inclined arm 115 of the plunger unit 110 engages with the locking recess 126 of the housing 120, and the end surface 113a of the tubular member 113 contacts the abutment surface 125a of the distal ring 125. Therefore, the plunger unit 110 is locked relative to the housing 120, thereby preventing any reuse of the injection device and allowing the used injection device to be safely disposed of.

[0077] End of medication indicator

[0078] The injection device according to the invention further comprises a reference Figures 12 to 16 The end-of-dose indicator 160 is shown. Note that for clarity, the plunger shaft 114 and the needle guard 130 are not shown. Figures 12 to 16 Shown in.

[0079] The end-of-dose indicator 160 may be located in the distal ring 125 of the housing 120, and the distal ring 125 may include a trigger opening 125b disposed in the abutment surface 125a and axially aligned to receive the longest rigid leg 112 of the plunger unit 110. In addition, the housing 120 may also include an indicator opening 127 configured to make at least a portion of the end-of-dose indicator 160 visible after the injection is completed.

[0080] refer to Fig.13 The dosing end indicator 160 includes a base 161, which contacts the elastic device 121 so as to receive the proximal force from the elastic device 121. The dosing end indicator 160 also includes at least one and preferably four flexible arms 162 protruding from the base 161 in the proximal direction, and each flexible arm 162 includes a terminal end provided with an abutment portion 162a and an inclined portion 162b.

[0081] End-of-dose indicator 160 can be moved from a hidden position in housing 120 where end-of-dose indicator 160 is hidden from the user to a visible position where at least a portion of end-of-dose indicator 160, such as tab 163, is visible to the user and / or protrudes out of housing 120 and / or through indicator opening 127. For example, tab 127 can be a portion of the end-of-dose indicator having a visible color and / or a visible design, such as a red rectangle or a rectangle with a red dot.

[0082] The housing 120 includes an indicator stop 128, such as one or two rigid arms pointing in the distal direction (e.g., inside the distal ring 125). Fig.12 and Fig.13 In the ready-to-use state shown, the abutment portion 162a of each flexible arm 162 is pushed against the indicator stop 128 of the housing 120 by the elastic means 121. Therefore, the end-of-dose indicator 160 is blocked in the hidden position by these hiding means. The elastic means can be the same spring as used for the needle guard or another concentric spring abutting the inner abutment surface of the distal ring 125.

[0083] When the plunger unit 110 moves from the initial proximal position to the final distal position, the trigger portion, such as the longest rigid leg 112, penetrates the distal ring 125 through the trigger opening 125b, such as Fig.14 16, wherein the longest rigid leg 112 is shown as transparent. When the plunger unit has reached the indicator position, which may be the second threshold position or the third threshold position, the longest rigid leg 112 contacts the inclined portion 162b of the flexible arm 162, and thus, the flexible arm deflects toward the tab 163. The contact between the abutment portion 162a of the flexible arm 162 and the indicator stop 128 is released, and these concealing devices are deactivated or unlocked, as shown. Fig.15 shown.

[0084] refer to Fig.15 , the end-of-dose indicator 160 can move freely to a visible position, and the tab 163 can pop out into the indicator opening 127, as shown in FIG. Fig.16 Due to the rapid triggering of the concealed device and the immediate movement of the end-of-dose indicator 160 to a visible position, the user and / or patient is informed that the substance has been completely injected without any ambiguity.

[0085] Other features and alternatives

[0086] Of course, it will be appreciated that obvious improvements and / or modifications may be implemented by those skilled in the art within the scope of the invention as defined by the appended claims.

[0087] For example, the elastic device is not limited to one or two cylindrical springs, but may also include any form of spring or elastic device. The outer surface of the tubular member may have ergonomic protrusions and may include an overmolded surface made of a smooth material. The guard stop 132 may have other designs other than protrusions, such as cavities or grooves.

[0088] The materials used to make this injection device are polypropylene, polycarbonate and / or acrylonitrile-butadiene-styrene. The barrel may comprise glass or plastic. Colors may be provided on various parts of the injection device, in particular on the tabs of the end-of-dose indicator. The window may be provided with graduations or indicators.

Claims

1. An injection device for injecting a substance into a body, comprising: a housing (120) comprising elastic means (121) and adapted to receive and retain a barrel (102) containing a substance to be injected, said barrel (102) comprising a bung (103) movable in sliding engagement within said barrel, a plunger unit (110) comprising a trigger portion, the plunger unit (110) being adapted to be coupled to the bung (103) and being movable relative to the housing (120) from an initial proximal position to a final distal position for injecting the substance when the barrel (102) enters the housing (120), - an end-of-dosing indicator (160) housed in the housing (120) and capable of moving under the force of the elastic means (121) from a hidden position in which the end-of-dosing indicator (160) is hidden from the user to a visible position in which at least a portion of the end-of-dosing indicator (160) is visible to the user, - a concealing device (128, 162) for locking the end-of-dose indicator (160) in the concealed position and configured to be actively unlocked by a trigger portion of the plunger unit when the plunger unit (110) reaches the indicator position during its injection movement, so as to allow the end-of-dose indicator (160) to automatically move to the visible position, wherein the concealing device comprises: - at least one indicator stop (128) disposed on one of the housing (120) and the end-of-dose indicator (160), - at least one flexible arm (162) disposed on the other of the housing (120) and the end-of-dose indicator (160) and arranged to contact the indicator stop (128) when the end-of-dose indicator (160) is in the hidden position, wherein the flexible arm (162) is configured to deflect under the action of the trigger portion of the plunger unit (110) to release contact with the adjacent surface, thereby unlocking the concealing device, wherein the trigger portion includes a rigid leg (112), and the flexible arm (162) includes an inclined portion (162b) forming an angle with a longitudinal axis of the rigid leg (112), wherein the housing (120) comprises a distal ring (125) in which the end-of-dose indicator (160) is accommodated, the distal ring (125) comprising a trigger opening (125b) and an indicator opening (127), the trigger opening being axially aligned to receive the rigid leg (112) of the plunger unit (110), and In order to unlock the concealment device, the rigid leg (112) penetrates the distal ring (125) through the trigger opening (125b), and when the plunger unit (110) has reached the indicator position, the rigid leg (112) contacts the inclined portion (162b) of the flexible arm (162) to deflect the flexible arm toward the protrusion (163), thereby releasing the contact between the adjacent portion (162a) of the flexible arm (162) and the indicator stop portion (128).

2. The injection device according to claim 1, wherein: The end-of-dose indicator (160) is adapted to move in a proximal direction from the concealed position to the visible position.

3. The injection device according to claim 1, wherein: The housing (120) includes a window (124), and wherein at least a portion of the end-of-dose indicator (160) includes the tab (163), the tab (163) being configured to pop out of the window (124) when the end-of-dose indicator (160) moves to the visible position.

4. The injection device according to any one of claims 1 to 3, wherein the plunger unit (110) comprises a tubular member (113) provided with the trigger portion, wherein the tubular member (113) is suitable for covering at least a portion of the housing (120) when the plunger unit (110) is in the final distal position.

5. The injection device according to claim 4, wherein: The tubular member (113) comprises an end face (113a), and the distal ring (125) defines an abutment surface (125a) adapted to abut the end face (113a) when the plunger unit (110) is in the final distal position.

6. The injection device according to claim 3, wherein: At least a portion of the window (124) is disposed on the distal ring (125).

7. The injection device according to any one of claims 1 to 3, further comprising the barrel (102) held in the housing (120), the barrel (102) containing a substance to be injected and comprising a stopper (103) and an injection needle (101) that can move in sliding engagement.

8. The injection device according to claim 7, further comprising: a needle guard (130) arranged to be movable under the force of the elastic means (121) from an injection position in which the needle guard (130) is movable relative to the injection needle (101) to a safety position in which the needle guard (130) permanently covers the injection needle (101), the needle guard being provided with a flexible leg (131) including a guard stop (132), the housing (120) further comprising an operation stop (122) configured to prevent the needle guard (130) from moving to the safety position by abutting the guard stop (132), The trigger portion is further configured to deflect the flexible legs (131) of the needle guard (130) when the plunger unit (110) has reached the trigger position during its injection movement so as to release the guard stop (132) and the operating stop (122) from abutment and allow the needle guard (130) to reach the safety position under the force of the elastic means.

9. The injection device according to claim 8, wherein: The indicator position is a threshold position located after the trigger position in the injection movement of the plunger unit (110).

10. The injection device according to claim 8, wherein: The injection device further comprises a safety lock, which is arranged to lock the needle guard (130) and / or the guard stopper (132) when the needle guard (130) is in the safety position.

11. The injection device according to claim 10, wherein: The safety lock comprises at least one flexible protrusion (123) arranged on the housing (120), and the trigger portion is further configured to deflect the flexible protrusion to place it in an adjacent position with the guard stop portion (132) when the plunger unit (110) has reached the safety lock position during its injection movement.